Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) today announced that it expects to present 11 scientific abstracts at the American Academy of Optometry (AAOpt) 2026 Annual Meeting, taking place Sept.
Tarsus Pharma (TARS) stock boosts XDEMVY sales guidance, delivers cash flow, and adds retina pipeline via acquisitions—see ...
Vyome Holdings, Inc. (Nasdaq: HIND) ("Vyome"), a clinical-stage biopharmaceutical company focused on immuno-inflammatory and rare disease conditions, today announced that the United States Patent and ...
Dry eye syndrome can be due to medications, aging, allergies, contact lenses, health conditions, and more. When you know what’s causing it, you can begin to address it.
Coats, OD, FAAO, explains how neurotrophic keratitis, demodex, cosmetic habits and mucus fishing complicate dry eye disease. Following the session, the Eye Care Network asked Coats about the ocular ...
A new in vitro study from Thailand found that lemongrass essential oil and extract formulations killed Demodex folliculorum mites within 44 minutes, outperforming the control and rivaling ivermectin.
Newspoint on MSN
Eye discharge: Excessive mucus is visible in the eyes early in the morning; know when it is a sign of danger?
Watery Eyes, Eye Health: During the night's sleep, mucus, oil, skin cells, and small particles accumulate in the corners of the eyes, due to which mud may appear in the eyes in the morning. Causes and ...
Sarah Farrant, Becci Zawadzki, and Kyla Black share how they would approach three dry eye scenarios in practice ...
REGN20423, a clinical-stage long-acting IL-13 monoclonal antibody invented and developed by Regeneron, is added to the alliance, along with a long-acting IL-4xIL-13 bispecific and two other ...
Harrow announced that 15 scientific abstracts featuring data from across its ophthalmic portfolio will be presented at two major eyecare meetings: American Academy of Optometry?s Annual ...
Tarsus Pharmaceuticals is scheduled to present at the American Academy of Optometry 2026 Annual Meeting in Anaheim from ...
A class action lawsuit claims that LiLash and LiBrow serums pose serious, undisclosed health risks to consumers due to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results